Primary chemotherapy with mitoxantrone and prednisone in advanced breast carcinoma. A phase II study
- 1 March 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (3) , 473-476
- https://doi.org/10.1016/s0277-5379(98)90019-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Mitoxantrone for the treatment of advanced breast cancer: Single-agent therapy in previously untreated patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Mitoxantrone in advanced breast cancer—a phase II study with special attention to cardiotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: Preliminary results of a phase II studyCancer Treatment Reviews, 1983
- Mitoxantrone (novantrone∗) as single agent and in combination chemotherapy in the treatment of advanced breast cancerCancer Treatment Reviews, 1983
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983
- Prospective evaluation of rotating chemotherapy in advanced breast cancerAmerican Journal of Clinical Oncology, 1983
- Chemotherapy of advanced breast cancer: A randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP)Cancer, 1981
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977